The results from a recent phase 3 trial indicate that mepolizumab significantly reduces moderate and severe exacerbations in patients with eosinophilic chronic obstructive pulmonary disease.
Recent studies show distinct metabolic disruptions in children with multisystem inflammatory syndrome in children, plaque progression in adults post–COVID-19, and surprising pneumococcal risk patterns.
...
A recent randomized clinical trial demonstrated that a nurse and social worker-led palliative telecare intervention improved quality of life, mental health, and disease-specific outcomes for patients with...
The FDA has proposed new draft guidance to improve the accuracy of pulse oximeters across all skin tones, addressing long-standing concerns about potential disparities in performance.
The FDA is seeking a cap on nicotine levels in cigarettes and certain tobacco products at minimally or nonaddictive levels. This initiative, if finalized, would be what the FDA calls a “significant step”...
A prospective study reveals that individuals with inflammatory bowel disease (IBD), ulcerative colitis, and Crohn disease have a significantly higher risk of developing chronic obstructive pulmonary disease...
The American Thoracic Society released a set of guidelines addressing the use of pulmonary rehabilitation in patients with chronic obstructive pulmonary disorder and other respiratory diseases.
Researchers determined the risk of death and health care costs in patients with COPD who undergo surgery compared with patients without COPD who undergo surgery.
In this clinical review, researchers outlined strategies for managing exacerbations of chronic obstructive pulmonary disease in the emergency department to reduce future exacerbations and hospital...
